CSL Limited

ASX:CSL.AX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

💉 Vaccines

Location

Australia

Market Cap

USD 85.37 B

Share Price

USD 176.44

Avg Daily Volume

756,901

Change (1 day)

2.25%

Change (1 year)

-9.77%

Change (YTD)

1.24%

CSL Limited Research and Development (R&D) Expenses for the year ending June 30, 2024: USD 1.43 B

CSL Limited Research and Development (R&D) Expenses is USD 1.43 B for the year ending June 30, 2024, a -22.11% change year over year. Research and development (R&D) expenses are the costs associated with the development of new products, technologies, or improvements to existing products.

CSL Limited Research and Development (R&D) Expenses for the year ending June 30, 2023 was USD 1.84 B, a 15.16% change year over year.
CSL Limited Research and Development (R&D) Expenses for the year ending June 30, 2022 was USD 1.59 B, a 58.18% change year over year.
CSL Limited Research and Development (R&D) Expenses for the year ending June 30, 2021 was USD 1.01 B, a 5.79% change year over year.
CSL Limited Research and Development (R&D) Expenses for the year ending June 30, 2020 was USD 952.77 M, a 17.18% change year over year.